Get the app
public
ios_share
OncoPharm
chevron_right
Pembrolizumab Nets 2 More Approvals
Jun 20, 2019
15:02
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Discussing recent FDA-approvals of pembrolizumab for metastatic or unresectable, recurrent Head & Neck Cancer (1st line) and Small Cell Lung Cancer (3rd line)
